| Literature DB >> 28273910 |
Tristan Pascart1,2, Guillaume Falgayrac3, Henri Migaud3,4, Jean-François Quinchon5, Laurène Norberciak6, Jean-François Budzik3,7, Julien Paccou3,8, Anne Cotten3,9, Guillaume Penel3, Bernard Cortet3,8.
Abstract
Non-traumatic osteonecrosis (ON) of the femoral head is a common disease affecting a young population as the peak age of diagnosis is in the 40 s. The natural history of non-traumatic ON leads to a collapse of the femoral head requiring prosthetic replacement in a 60% of cases. Although trabecular bone involvement in the collapse is suspected, the underlying modifications induced at a molecular level have not been explored in humans. Here, we examine changes in the molecular composition and structure of bone as evaluated by Raman spectroscopy in human end-stage ON. Comparing samples from femoral heads harvested from 11 patients and 11 cadaveric controls, we show that the mineral and organic chemical composition of trabecular bone in ON is not modified apart from age-related differences. We also show that the molecular composition in the necrotic part of the femoral head is not different from the composition of the remaining 'healthy' trabecular bone of the femoral head. These findings support that quality of trabecular bone is not modified during ON despite extensive bone marrow necrosis and osteocyte death observed even in the 'healthy' zones on histological examination.Entities:
Mesh:
Year: 2017 PMID: 28273910 PMCID: PMC5427816 DOI: 10.1038/s41598-017-00162-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Mean Raman spectra representative of the necrotic zone in osteonecrosis (ON) group and of the necrotic equivalent zone in the control (CTL) group.
Mean values ± Standard Deviation (Standard Error) for each physicochemical parameter for the necrotic, sclerotic and distant zones of the non-traumatic osteonecrosis (ON) of the femoral head group and equivalent zones of the control group.
| Group | Zone | Proteoglycan relative content | Collagen maturity | Hydroxyproline-to-proline ratio | Mineral-to-matrix ratio | Carbonate-B-substitution | Crystallinity |
|---|---|---|---|---|---|---|---|
| ON | Necrotic | 0.064 ± 0.004 (0.001) | 1.476 ± 0.058 (0.017) | 0.841 ± 0.114 (0.034) | 8.947 ± 0.688 (0.207) | 0.126 ± 0.004 (0.001) | 0.05 ± 0.001* (0.0003) |
| ON | Sclerotic | 0.061 ± 0.004* (0.001) | 1.464 ± 0.066 (0.020) | 0.869 ± 0.127 (0.038) | 9.018 ± 0.568 (0.171) | 0.127 ± 0.005 (0.002) | 0.049 ± 0.001* (0.0003) |
| ON | Distant | 0.061 ± 0.004 (0.001) | 1.492 ± 0.072 (0.022) | 0.841 ± 0.121 (0.036) | 8.913 ± 0.537 (0.162) | 0.126 ± 0.004 (0.001) | 0.049 ± 0.001* (0.0003) |
| Control | Necrotic equivalent | 0.075 ± 0.016 (0.005) | 1.505 ± 0.069 (0.021) | 0.763 ± 0.152 (0.046) | 9.624 ± 0.716 (0.216) | 0.126 ± 0.004 (0.001) | 0.051 ± 0.001 (0.0003) |
| Control | Sclerotic equivalent | 0.074 ± 0.015 (0.005) | 1.453 ± 0.066 (0.02) | 0.749 ± 0.136 (0.041) | 9.722 ± 0.640 (0.193) | 0.127 ± 0.003 (0.0009) | 0.051 ± 0.002 (0.0006) |
| Control | Distant equivalent | 0.075 ± 0.015 (0.005) | 1.465 ± 0.104 (0.031) | 0.752 ± 0.115 (0.035) | 9.411 ± 0.353 (0.106) | 0.127 ± 0.004 (0.001) | 0.051 ± 0.002 (0.0006) |
None of these differences were significant between zones within groups. *Corrected p-value < 0.05 (univariate between group differences, none of these differences were significant after multivariate analysis).
Figure 2Age-related distribution of crystallinity values.
Figure 3Histological examination using hemtoxylin-eosin-saffron staining. (A) Control sclerotic-equivalent zone (x200); (B). Necrotic zone (ON group) (x200); (C). Sclerotic zone (ON group) (x200); (D). Sclerotic zone with coexisting normal trabeculae, woven and chondroid bone (ON group) (x200); (E). pyknotic apoptotic osteocytes (ON group) (x400); (F). coexistence of pyknotic osteocytes others presenting with nuclei showing spread and faded chromatin (x400). &Normal trabecula, $woven bone, ¥chondroid bone, #normal medullary space, §necrotic medullary space, *intact osteocyte, ¶apoptotic osteocyte, ¤empty osteocyte lacuna. ON: osteonecrosis.
Disease history and patients’ characteristics.
| Patient number | Age (y.o) | Gender | Side | Bilateral osteonecrosis | Disease duration (months) | Cause | FICAT stage |
|---|---|---|---|---|---|---|---|
| 1 | 58 | male | Left | Unknown | 36 | Alcohol abuse | 4 |
| 2 | 45 | male | Left | Yes | 6 | Alcohol abuse | 3 |
| 3 | 46 | male | Right | Yes | 24 | Alcohol abuse | 3 |
| 4 | 64 | male | Right | Yes | 12 | Glucocorticoids use | 4 |
| 5 | 57 | male | Right | Yes | unknown | Alcohol abuse | 3 |
| 6 | 44 | male | Left | Yes | unknown | Alcohol abuse | 4 |
| 7 | 40 | male | Right | Yes | 36 | Alcohol abuse | 4 |
| 8 | 62 | male | Left | Yes | unknown | Alcohol abuse | 4 |
| 9 | 44 | male | Right | Unknown | unknown | Alcohol abuse | 4 |
| 10 | 60 | male | Right | Yes | unknown | Alcohol abuse | 4 |
| 11 | 37 | male | Right | Yes | 18 | Alcohol abuse | 3 |
Figure 4Magnetic resonance imaging (A) and macroscopic (B) localizations of the three sampled zones. Nec = necrotic zone, Scl = sclerotic zone, Dist = distant zone.
Figure 5Partial overview of a single sample in confocal microscopy (X10) with each of the 15 (/30 of the entire sample) selected spots selected for Raman spectral acquisition (red dots). *Marrow regions, &mineral trabeculae.